Gene · 9232
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Crosstalk between Plk1, p53, cell cycle, and G2/M DNA damage checkpoint regulation in cancer: computational modeling and analysis. | NPJ Syst Biol Appl | 2021 | 34887439 | PubTator, text mining | PubMed |
| BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity. | Molecules | 2021 | 34885726 | PubTator, text mining | PubMed |
| Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer. | Cancers (Basel) | 2021 | 34885228 | PubTator, text mining | PubMed |
| Identification of Key Genes Associated with Progression and Prognosis of Bladder Cancer through Integrated Bioinformatics Analysis. | Cancers (Basel) | 2021 | 34885040 | PubTator, text mining | PubMed |
| Comprehensive transcriptomic characterization reveals core genes and module associated with immunological changes via 1619 samples of brain glioma. | Cell Death Dis | 2021 | 34880206 | PubTator, text mining | PubMed |
| Emerging role of long noncoding RNAs in recurrent hepatocellular carcinoma. | World J Clin Cases | 2021 | 34877309 | PubTator, text mining | PubMed |
| Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma. | Front Cell Dev Biol | 2021 | 34869385 | PubTator, text mining | PubMed |
| Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology. | Front Oncol | 2021 | 34868996 | PubTator, text mining | PubMed |
| The Clinical Significance and Transcription Regulation of a DNA Damage Repair Gene, SMC4, in Low-Grade Glioma via Integrated Bioinformatic Analysis. | Front Oncol | 2021 | 34868977 | PubTator, text mining | PubMed |
| High-Throughput RNA Sequencing Reveals the Effect of NB-UVB Phototherapy on Major Inflammatory Molecules of Lesional Psoriasis. | Psoriasis (Auckl) | 2021 | 34858799 | PubTator, text mining | PubMed |
| Role of Flavonoids as Epigenetic Modulators in Cancer Prevention and Therapy. | Front Genet | 2021 | 34858475 | PubTator, text mining | PubMed |
| Conditional transcriptional relationships may serve as cancer prognostic markers. | BMC Med Genomics | 2021 | 34856998 | PubTator, text mining | PubMed |
| Predictive Value of miR-146a rs2431697 Polymorphism to Myelofibrosis Progression in Patients with Myeloproliferative Neoplasm. | Asian Pac J Cancer Prev | 2021 | 34837916 | PubTator, text mining | PubMed |
| Bioinformatics Analysis Identifies Precision Treatment with Paclitaxel for Hepatocellular Carcinoma Patients Harboring Mutant TP53 or Wild-Type CTNNB1 Gene. | J Pers Med | 2021 | 34834551 | PubTator, text mining | PubMed |
| The Roles of the Colon Cancer Associated Transcript 2 (CCAT2) Long Non-Coding RNA in Cancer: A Comprehensive Characterization of the Tumorigenic and Molecular Functions. | Int J Mol Sci | 2021 | 34830370 | PubTator, text mining | PubMed |
| Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis. | Technol Cancer Res Treat | 2021 | 34825846 | PubTator, text mining | PubMed |
| Single-cell transcriptome profiling reveals intratumoural heterogeneity and malignant progression in retinoblastoma. | Cell Death Dis | 2021 | 34815392 | PubTator, text mining | PubMed |
| Mechanistic Target of Rapamycin Complex 2 Regulation of the Primary Human Trophoblast Cell Transcriptome. | Front Cell Dev Biol | 2021 | 34805133 | PubTator, text mining | PubMed |
| Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer. | PLoS One | 2021 | 34797837 | PubTator, text mining | PubMed |
| Meta-Analysis of Esophageal Cancer Transcriptomes Using Independent Component Analysis. | Front Genet | 2021 | 34795689 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9232/papers?page=36